New Therapies Bring ‘Wins’ to Small Cell Lung Cancer Treatment - Cure Today
New Therapies Bring ‘Wins’ to Small Cell Lung Cancer Treatment Cure Today
🎗️
Онкология
Рак лёгких
277 материалов по теме, собраны автоматически из проверенных источников
Онкология
Katy Beckermann: AI’s Role in Transforming Multicenter Lung Cancer Research - Oncodaily
Katy Beckermann: AI’s Role in Transforming Multicenter Lung Cancer Research Oncodaily
🎗️
Онкология
Tagrisso Plus Orpathys Improves Progression-Free Survival in Lung Cancer - Cure Today
Tagrisso Plus Orpathys Improves Progression-Free Survival in Lung Cancer Cure Today
Онкология
Tip Sheet: Discoveries in Prostate Cancer, a New Liquid Biopsy for Small Cell Lung Cancer — and a National Clinical Trial Initiative for Acute Myeloid Leukemia | Newswise - newswise.com
Tip Sheet: Discoveries in Prostate Cancer, a New Liquid Biopsy for Small Cell Lung Cancer — and a National Clinical Trial Initiative for Acute Myeloid Leukemia | Newswise newswise.com
🎗️
Онкология
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors - Business Wire
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors Business Wire
🎗️
Онкология
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study - Y100 WNCY
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study Y100 WNCY
Онкология
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study - srnnews.com
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study srnnews.com
🎗️
Онкология
Baptist Cancer Center studying personalized mRNA vaccines to fight lung cancer - FOX13 Memphis
Baptist Cancer Center studying personalized mRNA vaccines to fight lung cancer FOX13 Memphis
Онкология
HUTCHMED (HCM) lung cancer combo tops China Phase III trial - Stock Titan
HUTCHMED (HCM) lung cancer combo tops China Phase III trial Stock Titan
Онкология
IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer - PR Newswire
IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer PR Newswire
Онкология
Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes - Medscape
Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes Medscape
🎗️
Онкология
Гинцбург: меланома и рак легких могут быть побеждены за 3-6 лет - Дзен
Гинцбург: меланома и рак легких могут быть побеждены за 3-6 лет Дзен
Онкология
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China - Yahoo Finance
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China Yahoo Finance
Онкология
Twice-daily radiation linked to better quality of life in lung cancer trial
Previously, the primary endpoint results of the NRG-LU005 (NCT03811002) study assessing the addition of the immunotherapy drug atezolizumab (Tecentriq) to standard-of-care concurrent chemoradiation for limited-stage small-cell lung cancer were reported at the American Society for Radiation Oncology 2024 Annual…
🎗️
Онкология
Could Lung Cancer Develop Differently in Younger Adults? – Oncogene Cancer Research - Oncodaily
Could Lung Cancer Develop Differently in Younger Adults? – Oncogene Cancer Research Oncodaily